Dasgupta et al., 2023 - Google Patents
Preclinical models of low-grade gliomasDasgupta et al., 2023
View HTML- Document ID
- 4773002517305510360
- Author
- Dasgupta P
- Balasubramanyian V
- de Groot J
- Majd N
- Publication year
- Publication venue
- Cancers
External Links
Snippet
Simple Summary Preclinical models are essential for the advancement of our understanding of glioma biology and the development of novel therapeutics. Much of our progress in the treatment of low-grade glioma has been hampered by our limited ability to develop ideal …
- 206010018338 Glioma 0 title description 112
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kaewkhaw et al. | Retinoblastoma: etiology, modeling, and treatment | |
| Bernal et al. | Telomeres: implications for cancer development | |
| Kolli et al. | CRISPR-Cas9 mediated gene-silencing of the mutant huntingtin gene in an in vitro model of Huntington’s disease | |
| Piergentili et al. | CRISPR-Cas and its wide-ranging applications: From human genome editing to environmental implications, technical limitations, hazards and bioethical issues | |
| Ain et al. | Extrachromosomal circular DNA: current knowledge and implications for CNS aging and neurodegeneration | |
| Fujihara et al. | Human globozoospermia-related gene Spata16 is required for sperm formation revealed by CRISPR/Cas9-mediated mouse models | |
| Noorani | Genetically engineered mouse models of gliomas: technological developments for translational discoveries | |
| Cho et al. | Genetically engineered mouse models for liver cancer | |
| Haase et al. | Hemispherical pediatric high-grade glioma: Molecular basis and therapeutic opportunities | |
| Dasgupta et al. | Preclinical models of low-grade gliomas | |
| Chen et al. | ABL genomic editing sufficiently abolishes oncogenesis of human chronic myeloid leukemia cells in vitro and in vivo | |
| Rabaan et al. | Application of CRISPR/Cas9 technology in cancer treatment: a future direction | |
| Wen et al. | CRISPR/Cas9-mediated TERT disruption in cancer cells | |
| Bailey et al. | CTCF expression is essential for somatic cell viability and protection against cancer | |
| Wei et al. | Mast cell-specific expression of human Siglec-8 in conditional knock-in mice | |
| Zikmund et al. | Loss of ISWI ATPase SMARCA5 (SNF2H) in acute myeloid leukemia cells inhibits proliferation and chromatid cohesion | |
| Koslová et al. | Knock-out of retrovirus receptor gene Tva in the chicken confers resistance to avian leukosis virus subgroups A and K and affects cobalamin (vitamin B12)-dependent level of methylmalonic acid | |
| Thomas Broome et al. | Assessing the anti-inflammatory activity of the anxiolytic drug buspirone using crispr-cas9 gene editing in lps-stimulated bv-2 microglial cells | |
| Hámori et al. | Establishment and characterization of a Brca1−/−, p53−/− mouse mammary tumor cell line | |
| Idilli et al. | Changes in the expression of pre-replicative complex genes in hTERT and ALT pediatric brain tumors | |
| Montesinos-Rongen et al. | Impact of a faulty germinal center reaction on the pathogenesis of primary diffuse large B cell lymphoma of the central nervous system | |
| Sinha et al. | RAD51-mediated DNA homologous recombination is independent of PTEN mutational status | |
| Begagić et al. | CRISPR/Cas9-mediated gene therapy for glioblastoma: a scoping review | |
| Brooks et al. | Challenges of gene editing therapies for genodermatoses | |
| Rocco et al. | Treatment of advanced non-small cell lung cancer with RET fusions: reality and hopes |